Pharma and Biotech
Result of AGM | 30-Jun-2025 | 13:45 | RNS |
Notice of AGM | 06-Jun-2025 | 11:00 | RNS |
Holding(s) in Company | 28-May-2025 | 07:00 | RNS |
£150,000 Convertible Loan Note Issue | 20-May-2025 | 07:00 | RNS |
Final results for the year ended 31 December 2024 | 30-Apr-2025 | 11:18 | RNS |
Contract in Caribbean and Update on CIZ1B | 28-Apr-2025 | 07:00 | RNS |
Appointment of Non-Executive Director | 25-Mar-2025 | 07:00 | RNS |
Update on Launch of CIZ1B Biomarker Assay | 24-Mar-2025 | 07:00 | RNS |
Appointment of Professor Dawn Coverley as CSO | 02-Jan-2025 | 07:00 | RNS |
Update on Strategic Partnership in North America | 16-Dec-2024 | 07:00 | RNS |
Execution of Agreement for North America | 21-Oct-2024 | 07:00 | RNS |
Update on Licensing and Partnership Agreement | 03-Oct-2024 | 13:12 | RNS |
Interim Results | 30-Sep-2024 | 07:00 | RNS |
Holding(s) in Company | 16-Sep-2024 | 07:00 | RNS |
Collaboration with Moffitt Cancer Center | 09-Sep-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 1.55p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 2.35 |
52 Week Low | 1.40 |
Volume | 101,780 |
Shares Issued | 396.39m |
Market Cap | £6.14m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:29 | 30,000 @ 1.64p |
15:12 | 585 @ 1.70p |
13:47 | 14 @ 1.70p |
13:11 | 22,000 @ 1.53p |
09:48 | 49,181 @ 1.53p |
Finance Director | Nigel Ronald Lee |
You are here: research